The Lancet (2021) This Phase 2 dose-finding trial randomized adults with overweight or obesity without diabetes to cagrilintide at doses from 0.3 to 4.5 mg weekly, placebo, or liraglutide 3.0 mg daily as an active comparator across 57 sites in 10 countries
Research use only: None of the peptide companies we reviewed sell FDA-approved medicines
Jhuang YH, Chung CH, Wang ID, et al
Taking more than one product can amount to more vitamin B12 than your body needs
Employer policies may vary While standard drug tests do not detect peptides, employer policies could theoretically address them through other means
Intramuscular injections must be delivered into the deltoid, vastus lateralis (thigh), or ventrogluteal site using a 11.5 inch, 2225 gauge needle at a 90-degree angle